OS9
Protein OS-9
Also known as: ERLEC2, OS-9, OS9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13438
- Gene
- OS9
- Ensembl
- ENSG00000135506
- Chromosome
- 12
- Canonical length
- 667 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a protein that is highly expressed in osteosarcomas. This protein binds to the hypoxia-inducible factor 1 (HIF-1), a key regulator of the hypoxic response and angiogenesis, and promotes the degradation of one of its subunits. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
667 residues, UniProt reviewed canonical sequence.
>Q13438|OS9
1 MAAETLLSSL LGLLLLGLLL PASLTGGVGS LNLEELSEMR YGIEILPLPV MGGQSQSSDV
61 VIVSSKYKQR YECRLPAGAI HFQREREEET PAYQGPGIPE LLSPMRDAPC LLKTKDWWTY
121 EFCYGRHIQQ YHMEDSEIKG EVLYLGYYQS AFDWDDETAK ASKQHRLKRY HSQTYGNGSK
181 CDLNGRPREA EVRFLCDEGA GISGDYIDRV DEPLSCSYVL TIRTPRLCPH PLLRPPPSAA
241 PQAILCHPSL QPEEYMAYVQ RQADSKQYGD KIIEELQDLG PQVWSETKSG VAPQKMAGAS
301 PTKDDSKDSD FWKMLNEPED QAPGGEEVPA EEQDPSPEAA DSASGAPNDF QNNVQVKVIR
361 SPADLIRFIE ELKGGTKKGK PNIGQEQPVD DAAEVPQREP EKERGDPERQ REMEEEEDED
421 EDEDEDEDER QLLGEFEKEL EGILLPSDRD RLRSEVKAGM ERELENIIQE TEKELDPDGL
481 KKESERDRAM LALTSTLNKL IKRLEEKQSP ELVKKHKKKR VVPKKPPPSP QPTEEDPEHR
541 VRVRVTKLRL GGPNQDLTVL EMKRENPQLK QIEGLVKELL EREGLTAAGK IEIKIVRPWA
601 EGTEEGARWL TDEDTRNLKE IFFNILVPGA EEAQKERQRQ KELESNYRRV WGSPGGEGTG
661 DLDEFDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OS9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 261 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 261 nTPM
- liver: 253 nTPM
- choroid plexus: 219 nTPM
- salivary gland: 184 nTPM
- parathyroid gland: 170 nTPM
- ovary: 161 nTPM
Single-cell type
- neutrophils: 301 nCPM
- esophageal apical cells: 270 nCPM
- lacrimal acinar cells: 247 nCPM
- syncytiotrophoblasts: 242 nCPM
- plasma cells: 207 nCPM
- extravillous trophoblasts: 197 nCPM
Immune cell
- eosinophil: 280 nTPM
- neutrophil: 253 nTPM
- classical monocyte: 247 nTPM
- total PBMC: 222 nTPM
- intermediate monocyte: 219 nTPM
- non-classical monocyte: 188 nTPM
Brain region
- choroid plexus: 150 nTPM
- hypothalamus: 101 nTPM
- thalamus: 96 nTPM
- medulla oblongata: 91 nTPM
- pons: 84 nTPM
- white matter: 81 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.05
- DepMap mean gene effect
- -0.28
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum unfolded protein response
- ERAD pathway
- negative regulation of retrograde protein transport, ER to cytosol
- protein retention in ER lumen
- protein targeting
- protein ubiquitination
- response to endoplasmic reticulum stress
- retrograde protein transport, ER to cytosol
- ubiquitin-dependent protein catabolic process
Molecular functions
- carbohydrate binding
- protease binding
- glycosylation-dependent protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OS9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OS9 as an antibody target. Whether an autoantibody or antibody against OS9 could matter depends on whether native OS9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OS9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OS9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...